Clinical trial
Bone Mineral Density and Subsequent Cancer Risk
NCT00340262 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00340262 |
|---|---|
| Title | Bone Mineral Density and Subsequent Cancer Risk |
| Official title | Bone Mineral Density and Subsequent Cancer Risk |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Endometrial Cancer, Breast Cancer |
| Enrollment | 15,595 |
| Start date | Apr 7, 2000 |
| Primary completion | Dec 31, 2004 |
| Completion | Mar 26, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | Mar 30, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: